N/A
N=83
Young Men's Health Project Targeting HIV Risk Reduction and Substance Abuse
HIV Infections
Bottom Line
View on ClinicalTrials.gov: NCT03577301 ↗Enrolled (actual)
83
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Illicit Drug Use Days — 3.17; 3.10; 3.25; 2.86 Number of Days — p=0.35
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Clinic-based Delivery (Behavioral); Remote Delivery (Behavioral); Multi-modal Delivery (Behavioral)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- Male
- Sponsor
- Florida State University
- Primary completion
- May 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Illicit Drug Use Days |
3.17; 3.10; 3.25; 2.86; 9.00; 5.12 | 0.35 |
| PRIMARY Condomless Anal Sex Acts |
5.9; 4.5; 6.9; 10.0; 3.1; 5.9 | 0.38 |
| PRIMARY Marijuana Use Days |
31.38; 34.09; 32.00; 19.00; 40.00; 32.75 | 0.73 |
| SECONDARY Alcohol Use Days |
20.17; 13.71; 17.62; 17.27; 20.60; 12.06 | 0.50 |
Summary
YMHP is a counseling intervention program for which the goals are to better understand HIV-prevention focused self-management behaviors among HIV-negative YMSM, and to study the implementation of YMHP to improve portability and scalability. The clinic sites will help investigators to assess and address practical problems at the frontline of service provision to pave the way for a comprehensive program to reduce HIV infection among YMSM that reflects the complexities of real world adolescent HIV clinics.
Eligibility Criteria
Inclusion Criteria
- HIV-negative test result from the past 90 days
- 15-24 years of age
- Born biologically male or currently identifying as male
- Sex with men in the past 90 days
- ≥ 3 days of illicit drug use in the past 90 days
- ≥ 1 episode of Condomless Anal Sex (CAS) in the past 90 days, or a positive STI test result in the past 90 days.
- Able to communicate in English
Exclusion Criteria
- Serious cognitive or psychiatric impairments
- Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)
Data sourced from ClinicalTrials.gov (NCT03577301). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.